Alle Studien
AutorisiertTherapeutische Anwendung (Phase IV)Interventionell

A long-term prospective monitoring study of all patients with Pompe Disease. Evaluating natural history, treatment response, disease markers and novel outcome measures.

Pompe disease is a rare condition that causes muscle weakness and breathing difficulties because the body cannot break down certain sugars properly. While treatments exist to help replace the missing enzyme, doctors still need more information about how well they work over many years. This long-term monitoring study follows adults living with Pompe disease who are receiving standard approved therapies, such as Myozyme, Nexviadyme, or Pombiliti with Opfolda. Rather than testing an experimental drug, researchers will observe participants during routine clinic visits. Taking part involves regular health checks, including simple walking tests, muscle strength checks, breathing measurements, and routine blood and urine tests. The goal is to build a clearer picture of how Pompe disease changes over a lifetime and how current treatments support everyday mobility and general quality of life.

Auf einen Blick

Status
Autorisiert
Phase
Therapeutische Anwendung (Phase IV)
Sponsor
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Einschreibeziel
180
Starten
01 Okt 2026

Worum geht es in dieser Studie?

Pompe disease (also known as acid maltase deficiency or glycogen storage disease type II) is a rare genetic condition. In people with Pompe disease, the body lacks enough of a specific enzyme needed to break down a complex sugar called glycogen. Over time, this sugar builds up inside cells, causing damage to muscles throughout the body, particularly the muscles used for moving and breathing.

Several approved treatments are now available to help manage Pompe disease. These include enzyme replacement therapies like Myozyme and Nexviadyme, as well as newer combined treatments like Pombiliti and Opfolda. However, because Pompe disease is rare, doctors still need more evidence about how people respond to these treatments over long periods. This study is a Phase IV monitoring trial, which means it observes patients using approved treatments in ordinary clinical care rather than testing unproven experimental medicines.

By following patients over time, the research team aims to track natural disease changes, monitor how well medications preserve muscle and lung power, and test new ways to measure wellbeing. The information gathered will help specialist clinics provide better, more personalised care for people living with Pompe disease in the UK and worldwide.

Wichtige Erkenntnisse

  • A long-term study monitoring adults living with Pompe disease.
  • Focuses on tracking muscle strength, breathing, and real-world response to approved treatments.
  • Involves routine assessments such as walking tests, lung checks, and questionnaires.
  • Does not require testing an unlicensed experimental medicine.
  • Participation is voluntary and runs alongside your normal specialist clinic appointments.

Wer könnte berechtigt sein?

This study is designed for adults aged 18 and over who have a confirmed diagnosis of Pompe disease (acid maltase deficiency). Both men and women can join.

Participants are typically people who are either receiving one of the approved medications for Pompe disease—such as Myozyme, Nexviadyme, or Pombiliti with Opfolda—or who are being monitored by a specialist metabolic team.

Your hospital doctor can check whether your diagnosis and current treatment plan fit the study requirements. Because this is an observational monitoring study, having other health conditions will not necessarily stop you from joining, provided you are able to complete the routine clinic assessments.

Könnte diese Studie für Sie geeignet sein?

Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.

  1. I am aged 18 or older.
  2. I have a confirmed medical diagnosis of Pompe disease (glycogen storage disease type II).
  3. I am currently receiving or being considered for standard Pompe disease treatment.
  4. I am able to attend regular clinic appointments for health checks.
  5. I am willing to share test results and complete quality-of-life questionnaires.
Beantworten Sie jede Frage, um Ihr Ergebnis zu sehen.

Was beinhaltet die Teilnahme?

Taking part mainly involves having your health tracked during regular clinic appointments over an extended period. Because this is a long-term monitoring study, it will run for several years alongside your standard NHS care. You will continue taking your prescribed Pompe disease medication as directed by your specialist.

During your visits, the research team will carry out standard physical checks. These include timed walking and movement tests (such as seeing how far you can walk in six minutes or how easily you can stand from a chair), muscle strength checks, and breathing tests (measuring your lung power while sitting and lying down). You will also give routine blood and urine samples and complete short questionnaires about your daily energy, mobility, and quality of life. In some cases, tests to check heart function or sleep patterns may also be reviewed.

Potenzielle Risiken und Vorteile

There is no guarantee that taking part will improve your health directly, but having extra, structured monitoring means your specialist team keeps a very close eye on your muscle and lung function. The main benefit is helping doctors learn how best to treat Pompe disease for you and future patients. Because the medicines in this study are already approved, the main physical risks are the known side effects of your prescribed treatment, which your doctor will explain. Some physical tests may leave you feeling temporarily tired. Joining is entirely voluntary, and you are free to leave the study at any time without your regular NHS care being affected.

Standorte (1)

Einige Standortangaben sind ungefähr. Wir arbeiten daran, dies zu verbessern — bitte überprüfen Sie die Angaben mit dem Versuchsteam, bevor Sie reisen.
  • —
    Unbestätigt
    Niederlande

Häufige Fragen

Will I have to try an experimental new drug?

No. This study monitors patients using approved treatments that are already licensed for Pompe disease, such as Myozyme, Nexviadyme, or Pombiliti and Opfolda.

Wie lange dauert die Studie?

This is a long-term follow-up study designed to track your health over several years as part of your regular ongoing hospital reviews.

Are the physical tests painful?

No. The tests involve simple walking tasks, breathing into a mouthpiece, and standard muscle checks. Some exercises may feel tiring, but you can rest whenever you need to.

Will taking part cost me anything?

No. The study assessments are done during clinical visits. Your standard treatment is provided through your specialist clinic, and taking part does not add treatment costs.

Kann ich die Studie verlassen, wenn ich meine Meinung ändere?

Yes. You can withdraw from the study at any point. You do not have to give a reason, and your routine medical treatment will continue as normal.

Wie Sie mehr erfahren können

Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.

Diskussion

Community-Diskussion

Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.